| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-06 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |